NINR Seeks Biomarker, Imaging Studies of Mild Cognitive Impairment | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biomarkers, genetic information, and neuroimaging tools could be used to detect and enable preventative treatment of neurodegenerative diseases before the onset of clinical symptoms, and the National Institute of Nursing Research plans to use $2.5 million this year to stimulate new research into this potential.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.